Showing results (231-240 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|February 2, 2006
An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemiaLucas Chan, Nicola R Hardwick, Barbara-ann Guinn, et al.Cancer Immunology, Immunotherapy : CII|February 3, 2006
Expression of macrophage-derived chemokine (MDC)/CCL22 in human lung cancerToru Nakanishi, Kazuyoshi Imaizumi, Yoshinori Hasegawa, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1991
Two monoclonal antibodies against small-cell lung cancer show existence of synergism in bindingS Saito, T Inoue, I Kawase, et al.Cancer Immunology, Immunotherapy : CII|January 24, 2006
Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation techniqueAnette Knudsen, Sissel E Monstad, Anne Dørum, et al.Cancer Immunology, Immunotherapy : CII|December 1, 1996
Hematopoietic augmentation by a beta-(1,4)-linked mannanS F Egger, G S Brown, L S Kelsey, et al.Cancer Immunology, Immunotherapy : CII|December 1, 1996
Apoptosis in antibody-dependent monocyte-mediated cytotoxicity with monoclonal antibody 17-1A against human colorectal carcinoma cells: enhancement with interferon gammaK Takamuku, K Baba, S Arinaga, et al.Cancer Immunology, Immunotherapy : CII|December 1, 1996
Heat-shock protein 72 cell-surface expression on human lung carcinoma cells in associated with an increased sensitivity to lysis mediated by adherent natural killer cellsC Botzler, R Issels, G MulthoffCancer Immunology, Immunotherapy : CII|September 1, 1996
The concurrent administration of OK432 augments the antitumor vaccination effect with tumor cells by sustaining locally infiltrating natural killer cellsS Kurosawa, M Harada, Y Shinomiya, et al.Cancer Immunology, Immunotherapy : CII|September 1, 1996
Induction of an antibody response in mice against human papillomavirus (HPV) type 16 after immunization with HPV recombinant Salmonella strainsM R Krul, E J Tijhaar, J A Kleijne, et al.Cancer Immunology, Immunotherapy : CII|August 1, 1993
Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAbM Caraglia, P Tagliaferri, P Correale, et al.Pageof 650